BNET Industries

Amazon Biotech Inc.

(AMZO) is in the Pharma Industry

Market Cap:$744.8K
  • Public
  • US
Dow Jones Description

We are a development stage company that was established to focus on the research and development of novel all-natural drugs for a better quality of life by using the best of traditional medicines from nature. Our goal is to be a world leader and contributor in the treatment of HIV naturally through the use of immune-based therapies. An immune-based therapy is defined as any treatment geared toward reestablishing proper functioning of the immune system or directly helping the immune system to fight a virus, i.e. HIV/AIDS. Our executive offices currently consist of shared office space located at 43 West 33rd Street, Suite 405, New York, NY 10001 and telephone number (212) 947-3362, and shared offices at Ofer Building, 5 Nahum Hefzadi Street, Jerusalem, Israel 95484. We maintain a website at www.amazonbiotech.com. Our Business Corporate History In 1994, Advanced Plant Pharmaceutical, Inc., a Delaware corporation, developed an investigational new drug now knows as AMZ 0026. On June 5, 2003, Amazon Biotech, Inc., a Delaware corporation, purchased the assets of Advanced Plant Pharmaceutical, Inc., including its AMZ 0026 drug and all accompanying rights.

Clinical and Regulatory Operations DirectorAvraham Harris
Number of Employees 6
Contact Information

43 W 33rd St Ste 405

New York, New York 10001

www.amazonbiote...

(212) 947-3362

NAICS Code Pharmaceutical Preparation Manufacturing: 325412

News & Analysis

Filter by

amazon biotech inc. - All News and Analysis

  • Amazon Biotech Announces Appointment of Chaim J. Lieberman, the Inventor and Founder, as New Successor for Management

    - 2008-10-27

    Amazon Biotech, Inc. (PINKSHEETS: AMZO)(FRANKFURT: B2DA) announced that Mr. Chaim J. Lieberman, the inventor andfounder of Amazon Biotech Inc., was appointed as sole successor formanagement to Mr. Eliyahu Bental/Tolchinsky and Mr. Bental resigned. Mr. Lieberman is quoted as saying,"I look forward to investing good energyto focus the company on its...

  • Amazon Biotech Announces Filing of 14A to Set Shareholder Meeting

    - 2008-09-26

    Amazon Biotech, Inc. (PINKSHEETS: AMZO)(FRANKFURT: B2DA) announced that a preliminary 14A was filed by Amazon toset a shareholder meeting, at a time to be announced, to elect a threemember Board of Directors and to address such other matters as may properlycome before the meeting or any adjournments thereof. Amazon Biotech,...

  • Amazon Biotech Announces Postponement of Shareholder Meeting on 14A Filing

    - 2008-07-17

    Amazon Biotech, Inc. (PINKSHEETS: AMZO)(FRANKFURT: B2DA) announced that the 14A shareholder meeting set for July17, 2008, to elect a three member Board of Directors and to address suchother matters that may properly come before the meeting has beenpostponed in order to allow time to file a preliminary 14A...

  • Amazon Biotech Announces Filing of 14A to Set Shareholder Meeting

    - 2008-07-07

    Amazon Biotech, Inc. (PINKSHEETS: AMZO)(FRANKFURT: B2DA) announced that a 14A was filed by Amazon setting ashareholder meeting for July 18, 2008, to elect a three member Board ofDirectors and to address such other matters as may properly come before themeeting or any adjournments thereof. The entire 14A filing may be...

  • Amazon Biotech Informs Shareholders of Unauthorized 8K Filing

    - 2008-06-17

    Amazon Biotech, Inc. (OTCBB: AMZO) (FRANKFURT: B2DA) announced that an 8K was filed by Amazon's former employee, MichaelKanovsky, on June 13, 2008, alleging that a written consent of the Board ofDirectors issuing shares as compensation in lieu of debt owed to a creditorof the company was never signed by the...

  • Amazon Biotech Announces Appointment of Dr. Michael Silver as New Scientific Director

    - 2008-05-29

    Amazon Biotech, Inc. (OTCBB: AMZO) (FRANKFURT: B2DA.F) announced that Dr. Michael Silver has been appointed as thecompany's new Scientific Director. Dr. Silver has over 15 years of experience in the biotechnology,pharmaceutical and medical device industries serving as Director ofBusiness Development and Senior Scientist at Bio-Imaging Technologies,Inc., as Director of Scientific...

  • Amazon Biotech Announces Appointment of New CEO and New Corporate Counsel

    - 2008-05-21

    Amazon Biotech, Inc. (OTCBB: AMZO) (FRANKFURT: B2DA) announced that Mr. Eliyahu BenTal Tolchinsky has been appointed asdirector and Chief Executive Officer of the Company. Mr. Tolchinsky, a graduate of Cornell University and Tulane Law School, hasa strong background in Research and Development, intellectual propertyprotection and regulatory compliance. Mr. Tolchinsky has...

  • Amazon Biotech, Inc. Issues Shareholder Update of Corporate Developments

    - 2007-12-10

    Amazon Biotech, Inc. (OTCBB: AMZO)(FRANKFURT: B2D) has released the following update to shareholders: In the past six months, Amazon Biotech, Inc. has raised $215,000 in capitaland is in negotiations for a further $2.3 Million. Upon the successfulcompletion of funding the Company will focus on initiating phase I/IItrials for its AIDS...

  • Solar Energy Market is Booming!!

    - 2007-06-06

    M2 PRESSWIRE-6 June 2007-LiquidStockReport.com: Solar Energy Market is Booming!!C1994-2007 M2 COMMUNICATIONS LTD RDATE:06062007 Stocks to Watch: Open Energy Corporation (OTCBB: OEGY) , Dhanoa Minerals Ltd. (OTC BB:DHNA) , KAL Energy, Inc (OTC BB:KALG) , Oshkosh Truck Corporation (NYSE:OSK) , Amazon Biotech,...

  • MMUS, OPTM, PNTR, TSTC, AMZB, CYDF Have Also Been Added To Naked Short List Today.

    - 2007-05-22

    M2 PRESSWIRE-22 May 2007-BUYINS.NET: MMUS, OPTM, PNTR, TSTC, AMZB, CYDF Have Also Been Added To Naked Short List TodayC1994-2007 M2 COMMUNICATIONS LTD RDATE:22052007 BUYINS.NET, www.buyins.net, announced today that these select companies have been added to the NASDAQ, AMEX and NYSE naked...

Decision Makers

Name (plus bio) Position
Avraham Harris Clinical and Regulatory Operations Director
Dr Arthur Englard Scientific Director
Anthony J Mangia Expert Consultant
Kathleen K Casey Infectious Disease Specialist
Timothy M Casey Specialist and Dean of Cook College's Department

Board of Directors

Name (plus bio) Position
Dr Angelo Chinnici Board of Directors
Jeffrey L Gilbert Board of Directors
Organization Position Status
Amazon Biotech, Inc. Clinical and Regulatory Operations Director Current
Organization Position Status
Boston Scientific Corporation Strategic Partner Former
Columbia University College of Physicians and Surgeons Assistant Clinical Professor of Medicine Current
York University Mba Former
University of Toronto Bachelors of Commerce Former
Organization Position Status
Amazon Biotech, Inc. Expert Consultant Current
Amazon Biotech, Inc. Board of Directors Current
Organization Position Status
Amazon Biotech, Inc. Infectious Disease Specialist Current
Amazon Biotech, Inc. Board of Directors Current
The University of Medicine and Dentistry of New Jersey (UMDNJ) - Robert Wood Johnson Medical School Professor Former
Organization Position Status
Amazon Biotech, Inc. Specialist and Dean of Cook College's Department Current
Organization Position Status
Amazon Biotech, Inc. Board of Directors Current
Jersey Shore University Medical Center Former
Organization Position Status
Amazon Biotech, Inc. Board of Directors Current
advertisement
     AMZO $0.02 0.00 (0.00% )
Intraday | 3 Month | 6 Month | 1 Year
Average Volume 3,999
Shares Outstanding 17.10M
Market Cap 341.9K
Year High 0.18
Year Low 0.009
Earnings Per Share N/A
P/E Ratio -
Dividend N/A
Yield N/A
Glass Door

Pharma Industry Companies

Company Employer Rating
Pfizer 3.0
IndustryTop Rated

Brought to you by CBS MoneyWatch.com

advertisement